朝日新聞社2y
Shionogi’s anti-COVID-19 tablet wins emergency approval for use
The oral drug Xocova marks the first home-grown medication, developed by Shionogi & Co., which can be prescribed for patients with mild symptoms, suggesting a stable supply of the tablet will be ...
Business Wire4d
Late-Breaking at CROI 2025: SCORPIO-PEP Phase 3 Trial: Ensitrelvir is the First and Only COVID-19 Oral Antiviral to Demonstrate Prevention of COVID-19 as Post Exposure Prophylaxis
Ensitrelvir, known as Xocova ® in countries where it is approved, received emergency regulatory approval in Japan in 2022 and full approval in March 2024 for the treatment of COVID-19.
朝日新聞社2y
Panel again does not approve Shionogi’s pill to treat COVID-19
The name of the pill is Xocova, and its generic name is ensitrelvir ... Patients will be advised to take one tablet a day for five days if the pill is approved. Shionogi requested at the ...